Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 270, Issue 6 39-6, 1996, Pages

  Charles, Christopher J ^a,b   Espiner, Eric A ^a   Richards, A Mark ^a   Nicholls, M Gary ^a   Yandle, Timothy G ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

angiotensin aldosterone; arterial pressure; cardiac output; guanosine 3',5' cyclic monophosphate; metabolism of natriuretic peptides

Indexed keywords

ALBUMIN; ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CREATININE; CYCLIC GMP; HYDROCORTISONE; NATRIURETIC PEPTIDE TYPE C; POTASSIUM; SODIUM;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; HALF LIFE TIME; HEART OUTPUT; HORMONE METABOLISM; METABOLIC CLEARANCE RATE; NONHUMAN; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; SHEEP; SODIUM URINE LEVEL; SPECIES DIFFERENCE;

EID: 0029827491     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.270.6.r1324     Document Type: Article

References (33)

1. Aitken, G. D., P. George, and E. A. Espiner. Characterisation of ovine natriuretic peptide genomic DNA sequences (Abstract). J. Hypertens. 12, Suppl. 3: S174, 1994.
2. Charles, C. J., E. A. Espiner, V. A. Cameron, and A. M. Richards. Hemodynamic, renal, and endocrine actions of ANF in sheep: effect of 24-h, low-dose infusions. Am. J. Physiol. 258 (Regulatory Integrative Comp. Physiol. 27): R1279-R1285, 1990.
3. Charles, C. J., E. A. Espiner, and A. M. Richards. Cardiovascular actions of ANF: contributions of renal, neurohumoral, and hemodynamic factors in sheep. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R533-R538, 1993.
4. Charles, C. J., E. A. Espiner, A. M. Richards, M. G. Nicholls, and T. G. Yandle. Biological actions and pharmacokinetics of C-type natriuretic peptide in conscious sheep. Am. J. Physiol. 268 (Regulatory Integrative Comp. Physiol. 37): R201-R207, 1995.
5. Cheung, B. M. Y., J. E. C. Dickerson, M. J. Ashby, M. J. Brown, and J. Brown. Effects of physiological increments in human α-atrial natriuretic peptide and human brain natriuretic peptide in normal male subjects Clin. Sci. 86: 723-730, 1994.
6. Clavell, A. L., A. J. Stingo, L. L. Aarhus, and J. C. Burnett. Biological actions of brain natriuretic peptide in thoracic inferior vena caval constriction. Am. J. Physiol. 265 (Regulatory Integrative Comp. Physiol. 34): R1416-R1422, 1993.
7. Clavell, A. L., A. J. Stingo, C. M. Wei, D. M. Heublein, and J. C. Burnett. C-type natriuretic peptide: a selective cardiovascular peptide. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R290-R295, 1993.
8. Engel, A. M., J. R Schoenfeld, and D. G. Lowe. A single residue determines the distinct pharmacology of rat and human natriuretic peptide receptor-C. J. Biol. Chem. 269: 17005-17008, 1994.
9. Florkowski, C. M., A. M. Richards, E. A. Espiner, T. G. Yandle, and C. Frampton. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R1244-R1250, 1994.
10. Hama, N., H. Itoh, G. Shirakami, S. Suga, Y. Komatsu, T. Yoshimasa, I. Tanaka, K. Mori, and K. Nakao. Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem. Biophys. Res. Commun. 198: 1177-1182, 1994.
11. Holmes, S. J., E. A. Espiner, A. M. Richards, T. G. Yandle, and C. Frampton. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J. Clin. Endocrinol. Metab. 76: 91-96, 1993.
12. Hunt, P. J., A. M. Richards, E. A. Espiner, M. G. Nicholls, and T. G. Yandle. Bioactivity and metabolism of C-type natriuretic peptide (CNP) in normal man. J. Clin. Endocrinol. Metab. 78: 1428-1435, 1994.
13. Kenny, A. J., A. Bourne, and J. Ingram. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. Biochem. J. 291: 83-88, 1993.
14. Koller, K., D. Lowe, G. Bennett, N. Minamino, K. Kangawa, H. Matsuo, and D. Goeddel. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science Wash. DC 252: 120-123, 1991.
15. Lang, C. C., A. M. J. Choy, and A. D. Struthers. Atrial and brain natriuretic peptides: a dual natriuretic peptides system potentially involved in circulatory homeostasis. Clin. Sci. 83: 519-527, 1992.
16. Lewis, J. G., L. Manley, J. C. Whitlow, and P. A. Elder. Production of a monoclonal antibody to cortisol: application to a direct immunosorbent assay of plasma. Steroids 57: 82-85, 1992.
17. Lun, S., E. A. Espiner, M. G. Nicholls, and T. G. Yandle. A direct radioimmunoassay for aldosterone in plasma. Clin. Chem. 29: 268-271, 1983.
18. Maack, T., J. Okolicany, and G. Y. Koh. Functional properties of atrial natriuretic factor receptors. Semin. Nephrol. 13: 50-60. 1993.
19. McGregor, A., M. Richards, E. Espiner, T. Yandle, and H. Ikram. Brain natriuretic peptide administered to man: actions and metabolism. J. Clin. Endocrinol. Metab. 70: 1103-1107, 1990.
20. Nazario, B., R. M. Hu, A. Pedram, B. Prins, and E. R. Levin. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells. J. Clin. Invest. 95: 1151-1157, 1995.
21. Nicholls, M. G., and E. A. Espiner. A sensitive, rapid radioimmunoassay for angiotensin II. NZ Med. J. 83: 399-403, 1976.
22. Richards, A. M., D. McDonald, M. A. Fitzpatrick, M. G. Nicholls, E. A. Espiner, H. Ikram, S. Jans, and T. G. Yandle. Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations. J. Clin. Endocrinol. Metab. 67: 1134-1139, 1988.
23. Stingo, A. J., A. L. Clavell, D. M. Heublin, C. M. Wei, M. R. Pitteklow, and J. C. Burnett. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1318-H1321, 1992.
24. Suga, S., K. Nakao, M. Hosoda, M. Mukoyama, Y. Ogawa, G. Shirakami, H. Arai, Y. Saito, Y. Kambayashi, K. Inouye, and H. Imura. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130: 229-239, 1992.
25. Suga, S., K. Nakao, H. Itoh, Y. Komatsu, Y. Ogawa, N. Hama, and H. Imura. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β. Possible existence of "vascular natriuretic peptide system." J. Clin. Invest. 90: 1145-1149, 1992.
26. Tawaragi, Y., K. Fuchimura, S. Tanaka, N. Minamino, K. Kangawa, and H. Matsuo. Gene and precursor structures of human C-type natriuretic peptide. Biochem. Biophys. Res. Commun. 175: 645-651, 1991.
27. Totsune, K., K. Tabahashi, O. Murakami, F. Satoh, M. Sone, and T. Mouri. Elevated plasma C-type natriuretic peptide concentrations in patients with chronic renal failure. Clin. Sci. 87: 319-322, 1994.
28. Vesely, D. L., M. A. Douglass, J. R. Dietz, A. T. Giordano, M. T. McCormick, G. Rodriguez-Paz, and D. D. Shocken. Negative feedback of atrial natriuretic peptides. J. Clin. Endocrinol. Metab. 78: 1128-1134, 1994.
29. Wei, C. M., D. M. Heublin, M. A. Perrella, A. Lerman, R. J. Rodeheffer, C. G. McGregor, W. D. Edwards, H. V. Schaff, and J. C. Burnett. Natriuretic peptide system in human heart failure. Circulation 88: 1004-1009, 1993.
30. Wilcox, J. N., A. Augustine, D. V. Goeddel, and D. G. Lowe. Differential regional expression of three natriuretic peptide receptor genes within primate tissues. Mol. Cell. Biol. 11: 3454-3462, 1991.
31. Yandle, T. G., G. D. Aitken, S. F. Fisher, M. Rademaker, E. A. Espiner, and M. G. Nicholls. Ovine brain natriuretic peptide: identity measurement and regulation (Abstract). J. Hypertens. 12, Suppl. 3: S50, 1994.
32. Yandle, T. G., S. Fisher, C. Charles, E. A. Espiner, and A. M. Richards. The ovine hypothalamus and pituitary have markedly different distributions of C-type natriuretic peptide forms. Peptides 14: 713-716, 1993.
33. Yoshimura, M., H. Yasue, E. Morita, N. Sakaino, M. Jougasaki, M. Kurose, M. Mukoyama, Y. Saito, K. Nakao, and H. Imura. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 84: 1581-1588, 1991.